Modular Antibody–ADC Click Chemistry Overcomes Tumor Drug Resistance in Mice

Summary

Researchers demonstrated a modular antibody-ADC click chemistry approach using trans-cyclooctene and tetrazine ligation to overcome tumor drug resistance in mouse models. The preclinical study describes a potential platform technology for improving ADC therapeutics.